Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3Tumor-Agnostic 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1CNS 1

Conditions

Prostatic Neoplasms 50Neoplasm Metastasis 13Breast Neoplasms 9Carcinoma, Renal Cell 6Pain 5Osteoporosis 5Neoplasms 3Multiple Myeloma 3Kidney Neoplasms 3Lung Neoplasms 2Bone Neoplasms 2Bone Diseases, Metabolic 2Urologic Neoplasms 1Renal Insufficiency 1Insulin Resistance 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases 1

Interventions

pembrolizumab 28Docetaxel 21Gemcitabine 19Nivolumab 15Paclitaxel 13Prednisone 12Leuprolide 11pazopanib 10Radiotherapy 10Cisplatin 10Sunitinib 9Sorafenib 9Ipilimumab 8Blood Specimen Collection 8Bevacizumab 8avelumab 7atezolizumab 7Therapeutics 7Thalidomide 7Cyclophosphamide 7Carboplatin 7Standard of Care 6Radiation 6Mitomycin 6Interleukin-2 6Cetuximab 6Axitinib 6padeliporfin 5enzalutamide 5cemiplimab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasms × Zoledronic Acid × Genitourinary × Clear all
NCT00375648 2017-06-02

TRAPEZE

Novartis

Phase 3 Completed
61 enrolled
Genitourinary

Neoplasms, Pain, Prostatic Neoplasms

NCT00434317 2017-02-23

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Novartis

Phase 4 Completed
80 enrolled
BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

NCT01062503 2015-04-27

SubDueP

University Health Network, Toronto

Completed
48 enrolled
Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡